Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Lung Cancer
,
Oncology
Necitumumab Extends Survival of Patients with Squamous Lung Cancer
Read More
FDA Approvals
Idelalisib Approved for 3 Types of Hematologic Cancers
Read More
FDA Approvals
Belinostat Approved for Peripheral T-Cell Lymphoma
Read More
FDA Approvals
Palonosetron Indicated for CINV Prevention in Pediatric Patients
Read More
FDA Approvals
Zykadia for Metastatic, ALK-Positive Lung Cancer
Read More
FDA Approvals
Ramucirumab First Drug for Advanced Stomach Cancer
Read More
FDA Approvals
Ofatumumab Approved for Patients with CLL
Read More
FDA Approvals
Ibrutinib Approved for CLL
Read More
FDA Approvals
First Drug Combination Approved for Unresectable or Metastatic Melanoma
Read More
Site of Service Influences Value
Read More
143
144
145
146
147
148
149
Page 146 of 244
Results 1451 - 1460 of 2434